☆ 4.8 Article

Polymer Micropatches as Natural Killer Cell Engagers for Tumor Therapy

ACS NANO (2023)

Related references

Note: Only part of the references are listed.
Article Biotechnology & Applied Microbiology

Control of acute myeloid leukemia by a trifunctional NKp46-CD16a-NK cell engager targeting CD123

Laurent Gauthier et al.

Summary: Researchers have developed a novel natural killer cell engager (NKCE) that targets leukemia cells and has potent antitumor activity without toxicity, suggesting its potential for clinical development.

NATURE BIOTECHNOLOGY (2023)

Add to Collection
Review Chemistry, Multidisciplinary

Materials for Cell Surface Engineering

Kolade Adebowale et al.

Summary: Cell therapies have shown promise in treating previously incurable diseases, and the engineering of cell surfaces with various materials has emerged as a valuable tool to enhance their therapeutic performance. This review summarizes recent advances in decorating cell surfaces with nanoparticles, microparticles, and polymeric coatings, and highlights the benefits of surface modifications in protecting carrier cells, enhancing cell trafficking, and delivering therapeutic agents. While these technologies are still in the proof-of-concept stage, their promising efficacy from preclinical studies provides a strong foundation for future clinical translation, revolutionizing the field of cell therapies.

ADVANCED MATERIALS (2023)

Add to Collection
Article Multidisciplinary Sciences

A backpack-based myeloid cell therapy for multiple sclerosis

Neha Kapate et al.

Summary: We developed a myeloid cell-based strategy using backpack-laden monocytes to reduce disease burden in experimental autoimmune encephalomyelitis (EAE), a mouse model of progressive multiple sclerosis (MS). These backpack-laden monocytes regulated both the local and systemic immune responses and had therapeutic benefits by improving motor function. This approach offers a biomaterial-based method to precisely tune cell phenotype and demonstrates the utility of myeloid cells as a therapeutic modality and target.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Add to Collection
Article Hematology

Systemic IL-15 promotes allogeneic cell rejection in patients treated with natural killer cell adoptive therapy

Melissa M. Berrien-Elliott et al.

Summary: Using IL-15 for allogeneic cellular therapy may paradoxically limit therapeutic efficacy as it accelerates CD8 T-cell activation, leading to rejection of donor NK cells.

BLOOD (2022)

Add to Collection
Article Chemistry, Multidisciplinary

Manipulating Nanoparticle Aggregates Regulates Receptor-Ligand Binding in Macrophages

Yuri Kim et al.

Summary: In this study, the modulation of receptor-ligand interactions in cells using magnetic nanoparticle aggregates is investigated. Manipulating the accessible ligand dispersity can either promote macrophage adhesion and healing or suppress it depending on the ligand accessibility. This study presents accessible ligand dispersity as a novel parameter that regulates receptor-ligand binding and polarization of macrophages.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2022)

Add to Collection
Article Biochemistry & Molecular Biology

Natural killer cell dysfunction in cancer and new strategies to utilize NK cell potential for cancer immunotherapy

Wanze Zhang et al.

Summary: The dysfunction of immune cells is closely related to tumor progression and poor prognosis. In the tumor microenvironment, immunosuppressive factors inhibit the effector functions of immune cells, promoting tumor progression and metastasis. Dysfunctional NK cells, with weakened proliferation capacity and reduced production of effector cytokines, have limited ability to kill malignant cells and inhibit tumor progression. Reversing the dysfunctional state of NK cells and enhancing their effector functions is a promising strategy in cancer immunotherapy.

MOLECULAR IMMUNOLOGY (2022)

Add to Collection
Review Oncology

Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges

Alessandro Poggi et al.

Summary: The discovery of immune checkpoints and the development of specific blockers have revolutionized anti-cancer therapy. This review focuses on the potential of NK ICs as targets for dual-checkpoint inhibition, highlighting their role in NK cell survival and anti-tumor immune response.

MOLECULAR THERAPY-ONCOLYTICS (2022)

Add to Collection
Review Oncology

Emerging NK cell therapies for cancer and the promise of next generation engineering of iPSC-derived NK cells

Sainiteesh Maddineni et al.

Summary: This article reviews multiple approaches for allogeneic NK cell therapy and discusses the advantages and disadvantages of each method. In recent years, NK cells have become increasingly important players in the immune response against cancer.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Add to Collection
Review Oncology

Natural killer cells in clinical development as non-engineered, engineered, and combination therapies

Nina Lamers-Kok et al.

Summary: This review summarizes the clinical status of allogeneic NK cell-based therapies for hematological and solid tumors, discusses different cell sources, engineering methods, and combination therapies. It also reviews regulatory challenges and the competitive landscape, providing a comprehensive overview.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2022)

Add to Collection
Article Chemistry, Multidisciplinary

Artificial Antigen-Presenting Cell Topology Dictates T Cell Activation

Annelies C. Wauters et al.

Summary: This study systematically investigated the topological effects of polymersome-based aAPCs on T cell activation. The results showed that high ligand density and larger size of polymersomes enhance T cell activation. Furthermore, elongated polymersomes were found to be more effective in activating T cells compared to spherical or smaller counterparts.

ACS NANO (2022)

Add to Collection
Review Immunology

Overcoming tumor resistance mechanisms in CAR-NK cell therapy

Antonio Valeri et al.

Summary: Despite the successful results of autologous CAR-T cell therapy, CAR-NK immunotherapy offers a safer, faster, and cost-effective approach with no severe toxicities. However, resistance to CAR-NK cell therapy may arise due to various intrinsic or extrinsic mechanisms that affect NK cell function.

FRONTIERS IN IMMUNOLOGY (2022)

Add to Collection
Article Biochemical Research Methods

Protocol to isolate and analyze mouse bone marrow derived dendritic cells (BMDC)

Manuela Sauter et al.

Summary: This article describes an in vitro approach to analyze the role of CD11c+ cells and CD11c+-derived ApoE in atherosclerosis. The method involves harvesting mouse bone marrow, culturing the cells, treating them with differentiation factors, and collecting the cells after removing undesirable populations. This protocol can be adapted for different diseases and used to analyze cell-specific molecules.

STAR PROTOCOLS (2022)

Add to Collection
Review Oncology

Natural killer cells in antitumour adoptive cell immunotherapy

Tamara J. Laskowski et al.

Summary: This review provides an overview of NK cell-based immunotherapies, discussing strategies to increase NK cell cytotoxicity and persistence and highlighting the current challenges and future opportunities for the design of next-generation NK cell therapies.

NATURE REVIEWS CANCER (2022)

Add to Collection
Article Oncology

A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells

Upasana Sunil Arvindam et al.

Summary: The development of a CLEC12A TriKE molecule targeting AML blasts and LSCs, which activates NK cells and drives NK cell priming while sparing healthy cells, highlights the potential clinical efficacy for the treatment of AML.

LEUKEMIA (2021)

Add to Collection
Review Chemistry, Physical

Cell-bound nanoparticles for tissue targeting and immunotherapy: Engineering of the particle-membrane interface

Supriya Prakash et al.

Summary: This article critically analyzes the various properties that affect cell-nanomaterial interactions, discussing the physical properties of the cellular plasma membrane and the effects of NP properties and environmental conditions on the cell-NP interactions. Recent applications of cell-NP constructs for drug delivery, such as cellular hitchhiking, backpacking, and responsive surface attachment, are also reviewed.

CURRENT OPINION IN COLLOID & INTERFACE SCIENCE (2021)

Add to Collection
Review Biochemistry & Molecular Biology

Targeting metastatic cancer

Karuna Ganesh et al.

Summary: Improved understanding of metastases biology has led to advancements in targeting and treating both micro- and macrometastases. Recent studies have identified the unique biology of metastasis-initiating cells, providing new opportunities for developing more effective treatment strategies through cancer sequencing, mechanistic studies, and clinical trials. These insights offer potential for better outcomes in targeting metastatic relapse and improving patient survival.

NATURE MEDICINE (2021)

Add to Collection
Review Immunology

Engineering NK Cells for CAR Therapy-Recent Advances in Gene Transfer Methodology

Paula Schmidt et al.

Summary: The development of CAR-NK cells allows for harnessing the innate anti-tumor ability of NK cells against target tumor antigens, with the potential for creating an off-the-shelf therapeutic product applicable to most patients.

FRONTIERS IN IMMUNOLOGY (2021)

Add to Collection
Review Biotechnology & Applied Microbiology

Cell therapies in the clinic

Lily Li-Wen Wang et al.

Summary: Cell therapies have emerged as a promising therapeutic modality with unique advantages over conventional drugs, expanding therapeutic options and processes. They are currently a focus of investigation in both preclinical and clinical settings, with numerous approved products and ongoing clinical trials.

BIOENGINEERING & TRANSLATIONAL MEDICINE (2021)

Add to Collection
Article Engineering, Biomedical

Cancer-cell stiffening via cholesterol depletion enhances adoptive T-cell immunotherapy

Kewen Lei et al.

Summary: The study demonstrates that cancer cells enriched in cholesterol inhibit T-cell-mediated cytotoxicity, while stiffening cancer cells through cholesterol depletion enhances T-cell cytotoxicity, thereby improving the efficacy of adoptive T-cell therapy. This enhancement is attributed to increased T-cell forces at the immunological synapse, rather than influencing other T-cell functions like receptor signaling or production of cytolytic proteins. These findings suggest a mechanical immune checkpoint that could be targeted for improving cancer immunotherapies.

NATURE BIOMEDICAL ENGINEERING (2021)

Add to Collection
Article Multidisciplinary Sciences

IFN-γ-dependent NK cell activation is essential to metastasis suppression by engineered Salmonella

Qiubin Lin et al.

Summary: Cancer metastasis is a major cause of cancer-related deaths, and there is an urgent need for more clinically effective metastasis-targeting agents. The authors demonstrate in multiple mouse models of cancer that Salmonella YB1 inhibits metastasis through a mechanism dependent on IFN-gamma and NK cells.

NATURE COMMUNICATIONS (2021)

Add to Collection
Review Immunology

Natural killer cell engagers in cancer immunotherapy: Next generation of immuno-oncology treatments

Olivier Demaria et al.

Summary: Immuno-oncology is revolutionizing cancer treatment by inducing the immune system to recognize and eliminate tumor cells. Despite successes, alternative strategies are needed to broaden and strengthen anti-tumor immune responses.

EUROPEAN JOURNAL OF IMMUNOLOGY (2021)

Add to Collection
Article Hematology

Engineering the next generation of CAR-NK immunotherapies

Alexander Biederstaedt et al.

Summary: Cellular immunotherapy, particularly CAR-NK therapy, has shown promising efficacy in treating hematologic malignancies. Research is focused on enhancing CAR-NK cell potency and translating successful strategies to solid tumor treatments.

INTERNATIONAL JOURNAL OF HEMATOLOGY (2021)

Add to Collection
Review Cell & Tissue Engineering

Nonviral genome engineering of natural killer cells

Gabrielle M. Robbins et al.

Summary: NK cells have the potential to be a crucial part of cancer immunotherapy, but face challenges such as in vivo persistence and the tumor microenvironment. Enhancing NK cell resistance to tumor inhibitory signaling through genome engineering may improve their efficacy in cancer treatment.

STEM CELL RESEARCH & THERAPY (2021)

Add to Collection
Review Oncology

Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs

Cristina Capuano et al.

Summary: NK cells play a crucial role in cancer immunotherapy based on tumor-targeting monoclonal antibodies by interacting with IgG-opsonized tumor cells through the CD16 receptor. Activated NK cells not only exert cytotoxic functions but also produce a range of cytokines and chemokines to enhance adaptive immune responses. Strategies aiming to enhance NK cell-mediated antitumor functions in tumor-targeting monoclonal antibody regimens include mAb manipulation strategies and the potential exploitation of memory NK cells with unique characteristics.

CANCERS (2021)

Add to Collection
Review Oncology

NK Cell Therapy: A Rising Star in Cancer Treatment

Nawen Du et al.

Summary: Immunotherapy has become a popular cancer treatment approach, with a focus on the potential of natural killer (NK) cells to effectively combat cancer. NK cells have been shown to be reduced in cancer tissues and their immune function compromised, contributing to tumor growth. Efforts to increase NK cell numbers and activity for cancer treatment are ongoing, although challenges related to efficacy and safety remain.

CANCERS (2021)

Add to Collection
Review Oncology

From CAR-T Cells to CAR-NK Cells: A Developing Immunotherapy Method for Hematological Malignancies

Hui Lu et al.

Summary: The approval of CD19 CAR-engineered T cell products in B-cell malignancies is a breakthrough in CAR-T cell immunotherapy. However, limitations such as GVHD and other adverse effects restrict their wider applications. CAR-NK cells, with their unique characteristics, are considered promising candidates for cellular immunotherapy, offering potential off-the-shelf products for immediate clinical use without HLA-matching restrictions. Researchers are shifting focus from CAR-T cells to CAR-NK cells, discussing their advantages and challenges in clinical applications.

FRONTIERS IN ONCOLOGY (2021)

Add to Collection
Article Medicine, General & Internal

The Epidemiology of Lung Metastases

Hanbo Chen et al.

Summary: The study found that synchronous lung metastasis is relatively common in cancer patients and serves as an independent predictor of poor patient outcomes. The percentage of patients presenting with synchronous lung metastasis increased over time. Multivariable analysis revealed that de novo metastatic patients with synchronous lung metastases had worse overall survival.

FRONTIERS IN MEDICINE (2021)

Add to Collection
Article Biochemical Research Methods

Preparation and culture of bone marrow-derived macrophages from mice for functional analysis

Gotaro Toda et al.

Summary: This protocol details the collection and differentiation of bone marrow cells into bone marrow-derived macrophages for assessing macrophage function. For more information on the protocol's use and execution, refer to Toda et al. (2020).

STAR PROTOCOLS (2021)

Add to Collection
Review Oncology

Engineering strategies to overcome the current roadblocks in CAR T cell therapy

Sarwish Rafiq et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Add to Collection
Review Immunology

Characterizing the Dysfunctional NK Cell: Assessing the Clinical Relevance of Exhaustion, Anergy, and Senescence

Sean J. Judge et al.

FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2020)

Add to Collection
Article Polymer Science

Predicting the Miscibility and Rigidity of Poly(lactic-co-glycolic acid)/Polyethylene Glycol Blends via Molecular Dynamics Simulations

Martina Pannuzzo et al.

MACROMOLECULES (2020)

Add to Collection
Article Multidisciplinary Sciences

Cellular backpacks for macrophage immunotherapy

C. Wyatt Shields et al.

SCIENCE ADVANCES (2020)

Add to Collection
Review Oncology

Overcoming Heterogeneity of Antigen Expression for Effective CAR T Cell Targeting of Cancers

Sareetha Kailayangiri et al.

CANCERS (2020)

Add to Collection
Article Cell Biology

Understanding the Synergy of NKp46 and Co-Activating Signals in Various NK Cell Subpopulations: Paving the Way for More Successful NK-Cell-Based Immunotherapy

Loris Zamai et al.

CELLS (2020)

Add to Collection
Review Pharmacology & Pharmacy

NKp30-A prospective target for new cancer immunotherapy strategies

Pedro F. Pinheiro et al.

BRITISH JOURNAL OF PHARMACOLOGY (2020)

Add to Collection
Article Multidisciplinary Sciences

Trispecific natural killer cell nanoengagers for targeted chemoimmunotherapy

Kin Man Au et al.

SCIENCE ADVANCES (2020)

Add to Collection
Review Chemistry, Multidisciplinary

Mechanical Immunoengineering of T cells for Therapeutic Applications

Kewen Lei et al.

ACCOUNTS OF CHEMICAL RESEARCH (2020)

Add to Collection
Review Biochemistry & Molecular Biology

Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy

Yuqing Cao et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection
Article Biochemistry & Molecular Biology

Cytokines in the Treatment of Cancer

Kevin C. Conlon et al.

JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2019)

Add to Collection
Review Oncology

Mechanisms of resistance to CAR T cell therapy

Nirali N. Shah et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2019)

Add to Collection
Article Biochemistry & Molecular Biology

Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity

Laurent Gauthier et al.

CELL (2019)

Add to Collection
Review Immunology

The Natural Cytotoxicity Receptors in Health and Disease

Alexander David Barrow et al.

FRONTIERS IN IMMUNOLOGY (2019)

Add to Collection
Article Cell Biology

Natural Killer Cells Suppress T Cell-Associated Tumor Immune Evasion

Andrew J. Freeman et al.

CELL REPORTS (2019)

Add to Collection
Review Oncology

Cytokines in clinical cancer immunotherapy

Pedro Berraondo et al.

BRITISH JOURNAL OF CANCER (2019)

Add to Collection
Review Immunology

Driving CARs on the uneven road of antigen heterogeneity in solid tumors

Nan Chen et al.

CURRENT OPINION IN IMMUNOLOGY (2018)

Add to Collection
Article Biotechnology & Applied Microbiology

Scaffolds that mimic antigen-presenting cells enable ex vivo expansion of primary T cells

Alexander S. Cheung et al.

NATURE BIOTECHNOLOGY (2018)

Add to Collection
Article Biotechnology & Applied Microbiology

Enhancing T cell therapy through TCR-signaling-responsive nanoparticle drug delivery

Li Tang et al.

NATURE BIOTECHNOLOGY (2018)

Add to Collection
Article Immunology

CXCR3-deficient natural killer cells fail to migrate to B16F10 melanoma cells

Juyoung Kim et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2018)

Add to Collection
Article Oncology

Modulation of MHC class I surface expression in B16F10 melanoma cells by methylseleninic acid

Claudia Lennicke et al.

ONCOIMMUNOLOGY (2017)

Add to Collection
Article Chemistry, Multidisciplinary

Frizzled7 Antibody-Functionalized Nanoshells Enable Multivalent Binding for Wnt Signaling Inhibition in Triple Negative Breast Cancer Cells

Rachel S. Riley et al.

SMALL (2017)

Add to Collection
Article Cell Biology

Interferon-γ derived from cytotoxic lymphocytes directly enhances their motility and cytotoxicity

Purnima Bhat et al.

CELL DEATH & DISEASE (2017)

Add to Collection
Review Immunology

NK Cell exhaustion

Jiacheng Bi et al.

FRONTIERS IN IMMUNOLOGY (2017)

Add to Collection
Article Oncology

IL15 Trispecific Killer Engagers (TriKE) Make Natural Killer Cells Specific to CD33+ Targets While Also Inducing Persistence, In Vivo Expansion, and Enhanced Function

Daniel A. Vallera et al.

CLINICAL CANCER RESEARCH (2016)

Add to Collection
Article Chemistry, Multidisciplinary

Tuning Cellular Uptake of Molecular Probes by Rational Design of Their Assembly into Supramolecular Nanoprobes

Lye Lin Lock et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2016)

Add to Collection
Article Oncology

CXCL10-induced migration of adoptively transferred human natural killer cells toward solid tumors causes regression of tumor growth in vivo

Erik Wennerberg et al.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)

Add to Collection
Article Hematology

CD16xCD33 bispecific killer cell engager (BiKE) activates NK cells against primary MDS and MDSC CD33+ targets

Michelle K. Gleason et al.

BLOOD (2014)

Add to Collection
Article Immunology

IFN-γ Primes Macrophage Activation by Increasing Phosphatase and Tensin Homolog via Downregulation of miR-3473b

Cong Wu et al.

JOURNAL OF IMMUNOLOGY (2014)

Add to Collection
Article Medicine, Research & Experimental

Shielding of Lipid Nanoparticles for siRNA Delivery: Impact on Physicochemical Properties, Cytokine Induction, and Efficacy

Varun Kumar et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2014)

Add to Collection
Article Hematology

LAMP1/CD107a is required for efficient perforin delivery to lytic granules and NK-cell cytotoxicity

Konrad Krzewski et al.

BLOOD (2013)

Add to Collection
Article Cell Biology

Natural killer cell-produced IFN-γ and TNF-α induce target cell cytolysis through up-regulation of ICAM-1

Ruipeng Wang et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2012)

Add to Collection
Article Chemistry, Multidisciplinary

Cell-Based Drug Delivery Devices Using Phagocytosis-Resistant Backpacks

Nishit Doshi et al.

ADVANCED MATERIALS (2011)

Add to Collection
Article Biochemical Research Methods

A rapid method for assessment of natural killer cell function after multiple receptor crosslinking

Z. B. Al-Hubeshy et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2011)

Add to Collection
Article Cell Biology

IFN-γ production by lung NK cells is critical for the natural resistance to pulmonary metastasis of B16 melanoma in mice

Kazuyoshi Takeda et al.

JOURNAL OF LEUKOCYTE BIOLOGY (2011)

Add to Collection
Article Biotechnology & Applied Microbiology

Tumor Necrosis Factor-a Signaling in Macrophages

Narayanan Parameswaran et al.

CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2010)

Add to Collection
Article Chemistry, Multidisciplinary

Nanoparticle-Mediated IgE-Receptor Aggregation and Signaling in RBL Mast Cells

Yu-Fen Huang et al.

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)

Add to Collection
Article Immunology

IFN-γ arms human dendritic cells to perform multiple effector functions

Loredana Frasca et al.

JOURNAL OF IMMUNOLOGY (2008)

Add to Collection
Article Hematology

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

YT Bryceson et al.

BLOOD (2006)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.